Tobias Dittrich, MD, Heidelberg University, Heidelberg, Germany, compares and contrasts the different available cardiac staging systems in the field of AL amyloidosis. Dr Dittrich explains that overall, these staging systems are comparable and can accurately stratify patients with AL amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.